Literature DB >> 10714799

Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group.

L A Wallace1, K A McAulay, J D Douglas, A G Elder, D J Stott, W F Carman.   

Abstract

OBJECTIVES: To compare the conventional virus isolation method for diagnosis of influenza infection with reverse-transcription polymerase chain reaction (RT-PCR) in prospectively collected nose and throat swabs from elderly patients during the winter influenza season. The use of a denaturing buffer as an alternative to viral transport medium (VTM) for submission of combined nose and throat swabs to the laboratory for PCR was then investigated in a second study.
METHODS: Virus was cultured in microtitre plates using two different cell lines and detected using monoclonal antibody staining. A multiplex, matrix gene PCR assay was optimized to increase the sensitivity and specificity of detection of influenza A (H3 and H1) and B nucleic acid.
RESULTS: The multiplex assay detected all viruses with equal sensitivity to individual assays. In a large, multicentre field study PCR detected twice as many influenza infections compared with virus isolation. No positive culture was missed. PCR has a rapid turn around time (< 36 h) vs. a minimum of 7 days for virus isolation. Greater sensitivity and specificity in the PCR were achieved using a 'hot-start' method. Although the numbers were small, the detection rate using PCR was greater for swabs submitted in denaturing buffer than in VTM.
CONCLUSIONS: PCR significantly increased the sensitivity and clinical utility of influenza A (H3 and H1) and B diagnosis. There were a number of advantages in using denaturing buffer for submission of samples, including high sensitivity, rapidity, ease of use and no requirement for the virus to be viable on arrival at the laboratory. Therefore, PCR is a rapid, sensitive and user-friendly alternative for influenza diagnosis. Virus isolation technology should be limited to referral centres for further epidemiological characterization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10714799     DOI: 10.1016/s0163-4453(99)90053-1

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  10 in total

1.  Rapid virological surveillance of community influenza infection in general practice.

Authors:  W F Carman; L A Wallace; J Walker; S McIntyre; A Noone; P Christie; J Millar; J D Douglas
Journal:  BMJ       Date:  2000-09-23

2.  Evaluation of a new dot blot enzyme immunoassay (directigen flu A+B) for simultaneous and differential detection of influenza a and B virus antigens from respiratory samples.

Authors:  Jordi Reina; Emma Padilla; Fermin Alonso; Enrique Ruiz De Gopegui; Maria Munar; Margarita Mari
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

3.  Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA).

Authors:  B Herrmann; C Larsson; B W Zweygberg
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.

Authors:  Colin R Simpson; Nazir I Lone; Kim Kavanagh; Tanya Englishby; Chris Robertson; Jim McMenamin; Beatrix von Wissman; Eleftheria Vasileiou; Christopher C Butler; Lewis D Ritchie; Rory Gunson; Jürgen Schwarze; Aziz Sheikh
Journal:  Health Technol Assess       Date:  2020-12       Impact factor: 4.014

5.  Surveillance of childhood influenza virus infection: what is the best diagnostic method to use for archival samples?

Authors:  Brent Frisbie; Yi-Wei Tang; Marie Griffin; Katherine Poehling; Peter F Wright; Kathy Holland; Kathryn M Edwards
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study.

Authors:  Colin R Simpson; Nazir I Lone; Kimberley Kavanagh; Chris Robertson; Jim McMenamin; Beatrix von Wissmann; Eleftheria Vasileiou; Chris Butler; Lewis D Ritchie; Rory Gunson; Jürgen Schwarze; Aziz Sheikh
Journal:  BMJ Open       Date:  2017-02-28       Impact factor: 2.692

7.  Genetic and serologic surveillance of canine (CIV) and equine (EIV) influenza virus in Nuevo León State, México.

Authors:  Claudia B Plata-Hipólito; Sibilina Cedillo-Rosales; Nelson Obregón-Macías; Carlos E Hernández-Luna; Cristina Rodríguez-Padilla; Reyes S Tamez-Guerra; Juan F Contreras-Cordero
Journal:  PeerJ       Date:  2019-12-17       Impact factor: 2.984

8.  Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens-duration of symptoms significantly affects detection rate.

Authors:  Robin Brittain-Long; Johan Westin; Sigvard Olofsson; Magnus Lindh; Lars-Magnus Andersson
Journal:  J Clin Virol       Date:  2010-01-18       Impact factor: 3.168

9.  Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic techniques.

Authors:  Jodie L Simpson; Ivana Moric; Peter A B Wark; Sebastian L Johnston; Peter G Gibson
Journal:  J Clin Virol       Date:  2003-04       Impact factor: 3.168

10.  Virological surveillance of influenza-like illness in the community using PCR and serology.

Authors:  Lesley A Wallace; Terry C Collins; James D M Douglas; Sheena McIntyre; John Millar; William F Carman
Journal:  J Clin Virol       Date:  2004-09       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.